NYSE · ENOV
Enovis Corporation
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
Price chart by TradingView
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarEarnings announcement for ENOV: Nov 05, 2026
Enovis Corporation Common Stock is expected to report earnings on 11/05/2026 before market open. The report will be for the fiscal Quarter ending Sep 2026. According to Zacks Investment Research, based on 2 analysts' forecasts, the consensus EPS forecast for the quarter is $0.64. The reported EPS for the same quarter last year was $0.75.
| Fiscal quarter end | Consensus EPS forecast | High | Low | Estimates |
|---|---|---|---|---|
| Sep 2026 | $0.64 | $0.64 | $0.64 | 2 |
| Dec 2026 | $0.95 | $0.99 | $0.91 | 2 |
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
The Motley Fool · BNK Invest · Zacks · MarketBeat- The Motley Fool · Sep 14, 10:15 AM EDTInsider at Medical Device Maker Buys More Than 7,500 SharesThe acquisition involved 7,598 shares at a weighted average price of $19.74 per share, representing a total investment of ~$150,000.
- BNK Invest · Sep 8, 1:51 PM EDTTuesday 9/8 Insider Buying Report: ENOV, OBIOAs the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy — they expect to make money. So let's look at two noteworthy recent insider buys. At Enovis, a filing with the SEC revealed that on Friday, Chief Executive Officer D
- Zacks · Sep 3, 12:00 PM EDTWhat Makes Enovis (ENOV) a New Buy StockEnovis (ENOV) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
- Zacks · Sep 3, 9:35 AM EDTEnovis (ENOV) Loses 33% in 4 Weeks, Here's Why a Trend Reversal May be Around the CornerEnovis (ENOV) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
- Zacks · Sep 2, 1:33 PM EDTEnovis Boosts Surgical Robotics Portfolio With eCential AcquisitionENOV is set to acquire eCential Robotics to expand into orthopedic surgical robotics, though the deal is expected to pressure 2027 margins.
- MarketBeat · Sep 1, 10:03 AM EDTEnovis Targets Robotic Surgery Expansion With €155M eCential Robotics DealEnovis (NYSE:ENOV) said it has entered a binding offer to acquire eCential Robotics, a developer of surgical robotics technology, in a move the orthopedic company said will expand its enabling-technology capabilities and accelerate its pathway into robotic surgery. Chief Executi
- BNK Invest · Aug 17, 4:06 PM EDTEnovis (ENOV) Shares Cross Below 200 DMAIn trading on Monday, shares of Enovis Corp (Symbol: ENOV) crossed below their 200 day moving average of $25.24, changing hands as low as $24.56 per share. Enovis Corp shares are currently trading down about 5.5% on the day. The chart below shows the one year performance of EN
- MarketBeat · Aug 8, 2:03 AM EDTEnovis Q2 Earnings Call HighlightsEnovis (NYSE:ENOV) reported second-quarter 2026 sales of $583 million, up 3% on a reported basis and 5% organically, as growth in its Reconstruction business offset a slower but still expanding Performance & Recovery segment. Management said the company’s results reflected improv
- Zacks · Aug 6, 7:35 AM EDTEnovis (ENOV) Beats Q2 Earnings and Revenue EstimatesEnovis (ENOV) delivered earnings and revenue surprises of +8.43% and +0.15%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
- Zacks · Aug 5, 6:10 PM EDTCarlsmed, Inc. (CARL) Reports Q2 Loss, Beats Revenue EstimatesCarlsmed, Inc. (CARL) delivered earnings and revenue surprises of +2.50% and +2.27%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
- BNK Invest · Jul 14, 4:17 PM EDTEnovis Breaks Below 200-Day Moving Average – Notable for ENOVIn trading on Tuesday, shares of Enovis Corp (Symbol: ENOV) crossed below their 200 day moving average of $25.71, changing hands as low as $24.67 per share. Enovis Corp shares are currently trading off about 5.4% on the day. The chart below shows the one year performance of EN
- RTTNews · Jul 6, 11:12 PM EDTTop Biotech Gainers: LUCY Shines, SEER Gets Takeover Offer, OFIX, ENOV Rally On CMS Update(RTTNews) – Today's top gainers include Innovative Eyewear, which announced preliminary second-quarter net sales; Seer, following an acquisition proposal; and Orthofix and Enovis, which stand to benefit from CMS reimbursement reversal, among others.
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Company profile by TradingView
Financials
Loading fundamental data…
Fundamental data by TradingView
More headlines
More stories for Enovis Corporation from TradingView. Coverage varies.
Loading related news…
Related news by TradingView
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.